The small size of these studies, however, means they are not conclusive
When to monitor and how For patients on FDA-approved GLP-1 drugs, reasonable monitoring approach: Document baseline BP before starting Home BP monitor for patients with baseline hypertension or on antihypertensives
Therapeutic approaches targeting GLP-1 GLP-1 has been translated into multiple approved clinical therapies
I also take into consideration other factors that might impact an individuals particular needs
It has had very good weight loss, around 27% of total body mass, but the drop-out rate in the trial is 20% due to side effects, he says
Many people need to use them long term, combined with lifestyle changes, to keep the weight off.